Results 131 to 140 of about 7,704 (220)

Primary Hyperoxaluria Type 2 Masquerading as Chronic Kidney Disease of Unknown Origin in an Adolescent: A Case Report. [PDF]

Cureus
Garg M, Garg S, Mondal M, Acharya P, Garg L.   +4 more
europepmc   +1 more source

Global genetic prevalence estimates of primary hyperoxaluria are greater than previously reported. [PDF]

Clin Kidney J
Mandrile G, Rumsby G, Sciannameo V, Cogal AG, Glover M, Lieske JC, Harris PC.   +6 more
europepmc   +1 more source

Seven-year survival of renal transplant for oxalate nephropathy due to short-bowel syndrome [PDF]

, 2017
Brunner, F. P., Kistler, H., Peter, J., Thiel, G.   +3 more
core  

Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands. [PDF]

Nephrol Dial Transplant
Deesker LJ, Franssen CFM, Dorresteijn E, van de Kar NCAJ, Nurmohamed SA, Severs D, Garrelfs SF, Pisters-van Roy AAMG, Hollak CEM, Groothoff JW.   +9 more
europepmc   +1 more source

Piperacillin Pharmacokinetics in a Pediatric Patient With Primary Hyperoxaluria Receiving High-Dose Continuous Dialysis Post Liver-Kidney Transplant. [PDF]

J Pediatr Pharmacol Ther
Hagenauer M, Pavia K, Paice K, Girdwood ST, Hambrick HR.   +4 more
europepmc   +1 more source

Biosynthesis of complement C4 messenger RNA in normal human kidney [PDF]

, 1989
Bevec, Dorian, Felber, E., Feucht, Helmut E., Lang, M., Riethmüller, Gert, Weiss, Elisabeth H., Zwirner, Jörg   +6 more
core   +1 more source

Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN. [PDF]

Nephrol Dial Transplant
Deesker LJ, Oubram L, Almardini R, Baum MA, Bonilla-Felix M, Figueres L, Garrelfs SF, Groothoff JW, Ekulu PM, Müller RU, Oosterveld MJS, Qian S, Sayer JA, Soliman N, Moochhala SH, Bacchetta J.   +15 more
europepmc   +1 more source

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1. [PDF]

J Med Chem
Arias F, Rohilla S, Sixto-López Y, Richard KSE, Das S, Anand SK, Luque-Navarro PM, Bañuelos-Sanchez G, Pacheco-García JL, Gade R, McKinney MP, Kumar D, Maxie J, Corr WR, Pandey N, Kaur H, Ding J, Tan L, Scott E, Nam H, Gottlieb E, Orr AW, Dhanesha N, Yurdagul A, Pey AL, Franco-Montalbán F, Gómez Vidal JA, Rom O, Díaz-Gavilán M.   +28 more
europepmc   +1 more source

Intra-individual Comparative Study of Dynamic and Pharmacocavernography [PDF]

, 1989
Sommerkamp, H., Stief, Christian Georg, Wetterauer, Ulrich   +2 more
core   +1 more source

Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study. [PDF]

Orphanet J Rare Dis
Goldfarb DS, Chen JV, Zincavage R, Padilla B, Sussman M, Salem S, Modersitzki F.   +6 more
europepmc   +1 more source